$13.01
▼ -1.8% Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
Overview
52-week range
$7.36
$14
86% of range
Avg surprise (last 3)
-207.9%
Avg reaction (last 2)
+0.4%
50% positive
Latest IV / EM
89%
EM ±14.0% · $13 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.77 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.83 | $-0.88 | +5.7% | -25.8% | +1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.85 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.75 | $0.15 | -600.0% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $-0.66 | $-0.51 | -29.4% | — | -1.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.63 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.59 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.59 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.50 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.53 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.50 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $18M | — | $21M | $15M | $14M | — | — |
| Cost of revenue | $243,000 | $262,000 | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-73M | $-79M | — | $-80M | $-73M | $-65M | — | $-60M |
| Net income | $-68M | $-73M | — | $-74M | $-66M | $-57M | — | $-54M |
| EPS (diluted) | $-0.77 | $-0.83 | — | $-0.85 | $-0.75 | $-0.66 | — | $-0.63 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $70M | $39M | $149M | $95M | $82M | $51M | $224M | $49M |
| Inventory | $2M | $843,000 | $413,000 | — | — | — | — | — |
| Total current assets | $559M | $624M | $709M | $621M | $660M | $724M | $745M | $463M |
| Total assets | $588M | $653M | $738M | $649M | $682M | $744M | $760M | $479M |
| Long-term debt | $6M | $10M | $10M | $5M | $7M | $8M | $7M | $8M |
| Total liabilities | $539M | $545M | $564M | $407M | $377M | $379M | $347M | $55M |
| Total equity | $48M | $108M | $174M | $243M | $305M | $364M | $414M | $424M |